Myriad, ACLU Square Off At Gene Patent Hearings

Law360, New York (February 2, 2010, 3:36 PM EST) -- Balking at allegations that it had attempted to patent human thought, Myriad Genetics Inc. on Tuesday urged a federal judge to consider only the language of the patent laws as written when determining the validity of the company's patents covering isolated human genes.

Myriad, accused by medical groups and the American Civil Liberties Union of wrongly patenting the isolation and study of DNA strands linked to breast and ovarian cancer, defended its inventions as “new and useful” processes during hearings on the parties' cross-motions for summary...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.